Abstract:Osteoarthritis (OA) is the most prevalent degenerative joint disease. The highly regulated balance of matrix synthesis and degradation is disrupted in OA, leading to progressive breakdown of articular cartilage. The molecular events and pathways involved in chondrocyte disfunction of cartilage in OA are not fully understood. It is known that 1,25-dihydroxyvitamin D₃(1,25-(OH)2D3) is synthesized by macrophages derived from synovial fluid of patients with inflammatory arthritis. Vitmain D receptor is expressed in chondrocytes within osteoarthritic cartilage, suggesting a contributory role of 1,25-(OH)2D3 in the aberrant behavior of chondrocytes in OA. However, the physiological function of 1,25-(OH)2D3 on chondrocytes in OA remains obscure. Effect of 1,25-(OH)2D3 on gene expression in chondrocytes was investigated in this study. We found that 1,25-(OH)2D3 activated MMP13 expression in a dose-dependent and time-dependent manner, a major enzyme that targets cartilage for degradation. Interestingly, a specific mitogen-activated protein kinase p38 inhibitor SB203580, but not JNK kinase inhibitor SP600125, abrogated 1,25-(OH)2D3 activation of MMP13 expression. 1,25-(OH)2D3-induced increase in MMP13 protein level was in parallel with the phosphorylation of p38 in chondrocytes. To further address the effect of 1,25-(OH)2D3 on MMP13 expression, transfection assays were used to show that 1,25-(OH)2D3 activated the MMP13 promoter reporter expression. MMP13 is known to target type II collagen and aggrecan for degradation, two major components of cartilage matrix. We observed that the treatment of 1,25-(OH)2D3 in chondrocytes results in downregulation of both type II collagen and aggrecan while MMP13 was upregulated. Taken together, we provide the first evidence to demonstrate that 1,25-(OH)2D3 activates MMP13 expression through p38 pathway in chondrocytes. Since MMP13 plays a major role in cartilage degradation in OA, we speculate that the ability of 1,25-(OH)2D3 to potentiate MMP13 expression might facilitate cartilage erosion at the site of inflammatory arthritis.

Protein-disulfide Isomerase-associated 3 (Pdia3) Mediates the Membrane Response to 1,25-Dihydroxyvitamin D3 in Osteoblasts

Disruption of Pdia3 gene results in bone abnormality and affects 1alpha,25-dihydroxy-vitamin D3-induced rapid activation of PKC.

Impaired Bone Formation in Pdia3 Deficient Mice.

1α,25‐Dihydroxyvitamin D<sub>3</sub>Regulates the Expression of Membrane‐Type Matrix Metalloproteinase‐1 in Normal Human Osteoblast‐like Cells

Cellular responses to silencing of PDIA3 (protein disulphide-isomerase A3): effects on proliferation, migration and genes in control of active vitamin D

1alpha,25-dihydroxyvitamin D3 regulates the expression of membrane-type matrix metalloproteinase-1 in normal human osteoblast-like cells.

1α,25‐Dihydroxyvitamin D3 Regulates the Expression of Membrane‐Type Matrix Metalloproteinase‐1 in Normal Human Osteoblast‐like Cells

1,25(OH)2D3 Supports the Osteogenic Differentiation of Hpdlscs under Inflammatory Conditions Through Inhibiting PLAP-1 Expression Transcriptionally.

Effect of 1α, 25-Dihydroxyvitamin D3 on the Osteogenic Differentiation of Human Periodontal Ligament Stem Cells and the Underlying Regulatory Mechanism.

Osteogenic induction and 1,25-dihydroxyvitamin D3 oppositely regulate the proliferation and expression of RANKL and the vitamin D receptor of human periodontal ligament cells.

ClC-3 Chloride Channel Mediates the Role of Parathyroid Hormone [1-34] on Osteogenic Differentiation of Osteoblasts.

1Α,25-Dihydroxyvitamin D3 Induces the Expression of Membrane-type Matrix Metalloproteinase-1 in Normal Human Osteoblast-like Cells

Downregulation of the Ca2+-activated K+ channel KCa3.1 in mouse preosteoblast cells treated with vitamin D receptor agonist

Protein Disulfide Isomerase Family A Member 3 Knockout Abrogate Effects of Vitamin D on Cellular Respiration and Glycolysis in Squamous Cell Carcinoma

1α,25-Dihydroxyvitamin D3 inhibits the differentiation and bone resorption by osteoclasts generated from Wistar rat bone marrow-derived macrophages.

Morphological Approach to Biological Action of PTHrP and Vitamin D3 on Endochondral Ossification

1 Alpha,25-Dihydroxyvitamin D-3 Inhibits The Differentiation And Bone Resorption By Osteoclasts Generated From Wistar Rat Bone Marrow-Derived Macrophages

Genomically anchored vitamin D receptor mediates an abundance of bioprotective actions elicited by its 1,25-dihydroxyvitamin D hormonal ligand

Role of Gap Junction, Hemichannels, and Connexin 43 in Mineralizing in Response to Intermittent and Continuous Application of Parathyroid Hormone.

DDIT3 Regulates Cementoblast Mineralization by Isocitrate Dehydrogenase 1 Through Nuclear Factor‐κb Pathway

1,25-Dihydroxyvitamin D3 Activates MMP13 Gene Expression in Chondrocytes Through P38 MARK Pathway.